Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly MOD-4023 vs Daily Genotropin in Japanese Children with GHD
NCT03874013Phase 3Completed
- Sponsor
- OPKO Health
- Start
- Dec 2017
- Primary completion
- Mar 2020
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of somatrogon in growth hormone deficiency (GHD), sponsored by OPKO Health. Started Dec 2017; status: completed.
02
Drugs
somatrogon
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT03874013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03874013.